Apollo Medical Holdings Inc
NASDAQ:ASTH
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
32.96
62.54
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Apollo Medical Holdings Inc
Wall Street
Price Targets
ASTH Price Targets Summary
Apollo Medical Holdings Inc
According to Wall Street analysts, the average 1-year price target for
ASTH
is 64.76 USD
with a low forecast of 33.71 USD and a high forecast of 90.3 USD.
ASTH Last Price Targets
Apollo Medical Holdings Inc
The latest public price target was made on Oct 3, 2024 by
David Larsen
from
BTIG
,
who expects
ASTH
stock to
rise by 66%
over the next 12 months.
You can read more about this price target by viewing
the article on TheFly.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
|
David Larsen
BTIG
|
70
USD
Upside 66% |
1 month ago
Oct 3, 2024
|
Astrana Health price target raised to $70 from $60 at BTIG
TheFly
|
Michael Ha
Robert W. Baird
|
67
USD
Upside 59% |
3 months ago
Aug 15, 2024
|
Astrana Health price target raised to $67 from $54 at Baird
TheFly
|
Chris O'Cull
Stifel Nicolaus
|
48
USD
Upside 14% |
4 months ago
Jun 27, 2024
|
Astrana Health, Inc (ASTH) PT Raised to $48 at Stifel
StreetInsider
|
Price Targets
Operating Income
Forecast
Operating Income Estimate
Apollo Medical Holdings Inc
For the last 2 years the
compound annual growth rate for
Apollo Medical Holdings Inc's operating income is
-7%.
The projected
CAGR
for the next 3 years is
28%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ASTH's stock price target?
Price Target
64.76
USD
According to Wall Street analysts, the average 1-year price target for
ASTH
is 64.76 USD
with a low forecast of 33.71 USD and a high forecast of 90.3 USD.
What is Apollo Medical Holdings Inc's Revenue forecast?
Projected CAGR
27%
For the last 2 years the
compound annual growth rate for
Apollo Medical Holdings Inc's revenue is
34%.
The projected
CAGR
for the next 3 years is
27%.
What is Apollo Medical Holdings Inc's Operating Income forecast?
Projected CAGR
28%
For the last 2 years the
compound annual growth rate for
Apollo Medical Holdings Inc's operating income is
-7%.
The projected
CAGR
for the next 3 years is
28%.
What is Apollo Medical Holdings Inc's Net Income forecast?
Projected CAGR
19%
For the last 2 years the
compound annual growth rate for
Apollo Medical Holdings Inc's net income is
-6%.
The projected
CAGR
for the next 3 years is
19%.
You don't have any saved screeners yet
